Greater systolic blood pressure visit-to-visit variability was associated independently with increased risk of the composite kidney disease end point ( HR per @-SD increment , @ -LSB- @ % CI , @-@ @ -RSB- ; P = @ ) and end-stage renal disease , but not with the cardiovascular outcome .